Stay updated on Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe footer now identifies the site as revision v3.7.1 instead of v3.7.0; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record, replacing the expected study details. This indicates that the study content and related links are inaccessible from the public site, signaling an access restriction rather than an update to the study data.SummaryDifference21%

- Check29 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, signaling a new build deployment. This change represents a backend/software version increment and does not alter the displayed study details.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page shows a new revision line: Revision: v3.6.6, replacing v3.6.5, indicating a small documentation update. This update concerns only metadata and does not alter the study details or visible content.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, reflecting a small maintenance update to the page and no alterations to the study details.SummaryDifference0.0%

- Check79 days agoChange Detected- Revision updated from v3.6.3 to v3.6.4, indicating a platform/software update to the site. The change does not alter any study data or visible content on the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.